Investor New Enterprise Associates 15, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by New Enterprise Associates 15, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-14 13D/A ACLX / Arcellx, Inc. 3,745,262 3,055,360
2025-05-12 13D/A ACLX / Arcellx, Inc. 3,745,262 3,745,262
2025-03-10 13D/A SNTI / Senti Biosciences, Inc. 442,615 3,775,615
2024-12-26 13D/A NEUE / NeueHealth, Inc. 6,955,633 7,360,329
2024-12-04 13D/A SNTI / Senti Biosciences, Inc. 4,426,151 442,615
2024-10-08 13D/A RPHM / Reneo Pharmaceuticals, Inc. 4,785,494
2024-05-08 13D/A RPHM / Reneo Pharmaceuticals, Inc. 4,785,494 4,785,494
2024-05-02 13D/A DM / Desktop Metal, Inc. 14,270,746
2024-04-10 13D/A NEUE / NeueHealth, Inc. 6,213,259 6,955,633
2024-03-28 13D/A NKTX / Nkarta, Inc. 3,568,781 3,568,781
2024-02-14 13G/A INZY / Inozyme Pharma, Inc. 2,437,689
2023-12-22 13D/A NEUE / NeueHealth, Inc. 5,937,128 6,213,259
2023-09-28 13D/A NEUE / NeueHealth, Inc. 5,384,865 5,937,128
2023-08-21 13D/A NEUE / NeueHealth, Inc. 359,305,833 5,384,865
2023-06-23 13D/A ACLX / Arcellx, Inc. 4,746,494 3,745,262
2023-06-09 13D/A IONQ / IonQ, Inc. 26,306,693
2023-04-10 13D/A BGRY / Berkshire Grey Inc - Class A 38,183,023 38,183,023
2023-01-24 13D/A ACLX / Arcellx, Inc. 6,432,762 4,746,494
2022-12-12 13D/A EAR / Eargo, Inc. 4,526,082
2022-10-21 13D/A BHG / Bright Health Group, Inc. 262,123,444 359,305,833
2022-07-15 13D SNTI / Senti Biosciences, Inc. 4,426,151
2022-06-06 13D/A IONQ / IonQ, Inc. 29,229,659 26,306,693
2022-05-05 13D/A NKTX / Nkarta, Inc. 2,902,115 3,568,781
2022-05-05 13D/A HOOD / Robinhood Markets, Inc. 48,068,749
2022-02-17 13D ACLX / Arcellx, Inc. 6,432,762
2022-02-09 13D/A HOOD / Robinhood Markets, Inc. 74,790,858 48,068,749
2022-02-07 13G/A INZY / Inozyme Pharma, Inc. 2,437,689 2,437,689
2022-01-26 13D/A BHG / Bright Health Group, Inc. 218,153,625 262,123,444
2021-12-29 13D/A BHG / Bright Health Group, Inc. 218,153,625
2021-11-19 13G/A ANNX / Annexon, Inc. 2,495,687
2021-10-21 13D DMYI.U / dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f 29,229,659
2021-10-07 13D/A DM / Desktop Metal, Inc. 14,270,746
2021-08-26 13D HOOD / Robinhood Markets, Inc. 74,790,858
2021-08-16 13D BGRY / Berkshire Grey Inc - Class A 38,183,023
2021-06-22 13D/A DM / Desktop Metal, Inc. 19,270,746
2021-06-03 13D/A EAR / Eargo, Inc. 6,521,128 4,526,082
2021-04-23 13D RPHM / Reneo Pharmaceuticals, Inc. 4,785,494
2021-04-13 13D/A TPST / Tempest Therapeutics, Inc. 1,766,407 1,766,407
2021-02-12 13G ANNX / Annexon, Inc. 2,495,687
2021-02-12 13G INZY / Inozyme Pharma, Inc. 2,437,689
2020-12-28 13D DM.WT / Desktop Metal, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Com 28,263,413
2020-10-27 13D EAR / Eargo, Inc. 6,521,128
2020-07-23 13D NKTX / Nkarta, Inc. 2,902,115
2019-06-12 13D/A NITE / Capitol Series Trust - The Nightview Fund 6,662,532
2019-03-13 13D/A NITE / Capitol Series Trust - The Nightview Fund 6,662,532 6,662,532
2019-03-13 13D CMTA / Clementia Pharmaceuticals Inc. 2,706,283 2,706,283
2019-02-13 13G/A CMTA / Clementia Pharmaceuticals Inc. 2,140,246 2,706,283
2019-02-12 13G/A CRSP / CRISPR Therapeutics AG 3,216,021
2018-12-18 13D TPST / Tempest Therapeutics, Inc. 1,766,407
2018-10-09 13D/A NITE / Capitol Series Trust - The Nightview Fund 6,662,532
2018-02-12 13G/A CRSP / CRISPR Therapeutics AG 3,216,021 3,216,021
2018-01-29 13G CMTA / Clementia Pharmaceuticals Inc. 2,140,246
2017-10-17 13D OBSV / ObsEva SA. 4,586,563
2017-10-06 13D NITE / Capitol Series Trust - The Nightview Fund 6,162,532
2017-02-06 13G CRSP / CRISPR Therapeutics AG 3,216,021